rifampin and Hyperglycemia

rifampin has been researched along with Hyperglycemia* in 2 studies

Other Studies

2 other study(ies) available for rifampin and Hyperglycemia

Article	Year
Further experience on glucose tolerance test during rifampicin therapy. The Journal of the Association of Physicians of India, 1986, Volume: 34, Issue:2 Topics: Adult; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Male; Rifampin; Tuberculosis, Pulmonary	1986
Rifampicin-induced early phase hyperglycemia in humans. The American review of respiratory disease, 1982, Volume: 125, Issue:1 Early phase hyperglycemia, associated with increased rates of insulin and C-peptide secretion after oral administration of 100 g glucose, was observed among patients with pulmonary tuberculosis who were taking rifampicin. This early phase hyperglycemia appeared shortly after rifampicin was started and it disappeared completely a few days after rifampicin was discontinued. No difference in oral glucose tolerance was noted between healthy normal subjects and patients with pulmonary tuberculosis who were not taking any medications. Antituberculous drugs other than rifampicin did not induce early phase hyperglycemia. Because intravenous glucose tolerance was normal in patients treated with rifampicin, it is suggested that rifampicin produces an early phase hyperglycemia possibly by augmenting intestinal absorption of glucose. Topics: Administration, Oral; Adolescent; Aged; Antitubercular Agents; Blood Glucose; C-Peptide; Food; Glucose; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Male; Rifampin; Tuberculosis, Pulmonary	1982

Article

Year

Further experience on glucose tolerance test during rifampicin therapy.

The Journal of the Association of Physicians of India, 1986, Volume: 34, Issue:2

Topics: Adult; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Male; Rifampin; Tuberculosis, Pulmonary

1986

Rifampicin-induced early phase hyperglycemia in humans.

The American review of respiratory disease, 1982, Volume: 125, Issue:1

Early phase hyperglycemia, associated with increased rates of insulin and C-peptide secretion after oral administration of 100 g glucose, was observed among patients with pulmonary tuberculosis who were taking rifampicin. This early phase hyperglycemia appeared shortly after rifampicin was started and it disappeared completely a few days after rifampicin was discontinued. No difference in oral glucose tolerance was noted between healthy normal subjects and patients with pulmonary tuberculosis who were not taking any medications. Antituberculous drugs other than rifampicin did not induce early phase hyperglycemia. Because intravenous glucose tolerance was normal in patients treated with rifampicin, it is suggested that rifampicin produces an early phase hyperglycemia possibly by augmenting intestinal absorption of glucose.

Topics: Administration, Oral; Adolescent; Aged; Antitubercular Agents; Blood Glucose; C-Peptide; Food; Glucose; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Male; Rifampin; Tuberculosis, Pulmonary

1982